Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3404448rdf:typepubmed:Citationlld:pubmed
pubmed-article:3404448lifeskim:mentionsumls-concept:C0035983lld:lifeskim
pubmed-article:3404448lifeskim:mentionsumls-concept:C0040578lld:lifeskim
pubmed-article:3404448lifeskim:mentionsumls-concept:C0031715lld:lifeskim
pubmed-article:3404448lifeskim:mentionsumls-concept:C0027096lld:lifeskim
pubmed-article:3404448lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:3404448lifeskim:mentionsumls-concept:C1155937lld:lifeskim
pubmed-article:3404448lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:3404448pubmed:issue2lld:pubmed
pubmed-article:3404448pubmed:dateCreated1988-9-19lld:pubmed
pubmed-article:3404448pubmed:abstractTextPrevious studies have shown that muscarinic activation of airway smooth muscle in low Ca++ solutions increases myosin phosphorylation without increasing tension. Blocking Ca++ influx reduced phosphorylation, but not to basal levels. It was proposed that release of intracellular Ca++ contributed to dissociation of phosphorylation and contraction. To test this hypothesis the effects of ryanodine were studied under similar conditions. Ryanodine (10(-7) to 10(-5) M) antagonized caffeine-induced contraction of canine tracheal smooth muscle. Ryanodine also reduced carbachol-induced contractions and carbachol-induced myosin phosphorylation. The effect of ryanodine on potassium and serotonin-induced contractions was also investigated to test for a nonspecific inhibitory effect. In contrast to the effect on carbachol responses, ryanodine (10(-5) M) potentiated the contractile response to low concentrations of serotonin and potassium, but had no effect on the maximum response to either stimulant. Carbachol (10(-6) M) and ryanodine (10(-5) M) both significantly decreased 45Ca++ content of tracheal muscle. The effect of ryanodine and carbachol together on 45Ca++ content was not greater than either drug alone suggesting that ryanodine reduces the caffeine and carbachol responses by depleting releaseable Ca++ stores. Ryanodine significantly reduced Ca++-induced contraction and myosin phosphorylation in carbachol-stimulated muscle, suggesting that some of the Ca++ responsible for elevated phosphorylation is released from the sarcoplasmic reticulum.lld:pubmed
pubmed-article:3404448pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3404448pubmed:languageenglld:pubmed
pubmed-article:3404448pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3404448pubmed:citationSubsetIMlld:pubmed
pubmed-article:3404448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3404448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3404448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3404448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3404448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3404448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3404448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3404448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3404448pubmed:statusMEDLINElld:pubmed
pubmed-article:3404448pubmed:monthAuglld:pubmed
pubmed-article:3404448pubmed:issn0022-3565lld:pubmed
pubmed-article:3404448pubmed:authorpubmed-author:GerthofferW...lld:pubmed
pubmed-article:3404448pubmed:authorpubmed-author:KhoyiM AMAlld:pubmed
pubmed-article:3404448pubmed:authorpubmed-author:MurpheyK AKAlld:pubmed
pubmed-article:3404448pubmed:issnTypePrintlld:pubmed
pubmed-article:3404448pubmed:volume246lld:pubmed
pubmed-article:3404448pubmed:ownerNLMlld:pubmed
pubmed-article:3404448pubmed:authorsCompleteYlld:pubmed
pubmed-article:3404448pubmed:pagination585-90lld:pubmed
pubmed-article:3404448pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:3404448pubmed:meshHeadingpubmed-meshheading:3404448-...lld:pubmed
pubmed-article:3404448pubmed:meshHeadingpubmed-meshheading:3404448-...lld:pubmed
pubmed-article:3404448pubmed:meshHeadingpubmed-meshheading:3404448-...lld:pubmed
pubmed-article:3404448pubmed:meshHeadingpubmed-meshheading:3404448-...lld:pubmed
pubmed-article:3404448pubmed:meshHeadingpubmed-meshheading:3404448-...lld:pubmed
pubmed-article:3404448pubmed:meshHeadingpubmed-meshheading:3404448-...lld:pubmed
pubmed-article:3404448pubmed:meshHeadingpubmed-meshheading:3404448-...lld:pubmed
pubmed-article:3404448pubmed:meshHeadingpubmed-meshheading:3404448-...lld:pubmed
pubmed-article:3404448pubmed:meshHeadingpubmed-meshheading:3404448-...lld:pubmed
pubmed-article:3404448pubmed:meshHeadingpubmed-meshheading:3404448-...lld:pubmed
pubmed-article:3404448pubmed:meshHeadingpubmed-meshheading:3404448-...lld:pubmed
pubmed-article:3404448pubmed:meshHeadingpubmed-meshheading:3404448-...lld:pubmed
pubmed-article:3404448pubmed:meshHeadingpubmed-meshheading:3404448-...lld:pubmed
pubmed-article:3404448pubmed:meshHeadingpubmed-meshheading:3404448-...lld:pubmed
pubmed-article:3404448pubmed:meshHeadingpubmed-meshheading:3404448-...lld:pubmed
pubmed-article:3404448pubmed:year1988lld:pubmed
pubmed-article:3404448pubmed:articleTitleInhibition of tracheal smooth muscle contraction and myosin phosphorylation by ryanodine.lld:pubmed
pubmed-article:3404448pubmed:affiliationDepartment of Pharmacology, University of Nevada School of Medicine, Reno.lld:pubmed
pubmed-article:3404448pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3404448pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:3404448pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3404448pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3404448lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3404448lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3404448lld:pubmed